Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.18 +0.04 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Actinium Pharmaceuticals (ATNM) Return on Assets [ROA] (2011 - 2026)

Updated

Actinium Pharmaceuticals' Return on Assets [ROA] came in at 26.42% for Q2 2026, up 88.76 percentage points from -62.33% a year earlier and up 74.71 percentage points from the prior quarter.

Analysis

Actinium Pharmaceuticals (ATNM) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Actinium Pharmaceuticals' Return on Assets [ROA] was -52.67%, down 4.37 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +4.24 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -48.30% in FY2024 (+1.60 pp), -49.91% in FY2023 (-14.85 pp), -35.05% in FY2022 (-1.30 pp) and -33.76% in FY2021 (+23.16 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] in data going back to Q4 2011.
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of +9.05 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q2 2026 (a gain of 88.76 percentage points), and the weakest in Q3 2023 (a drop of 28.80 percentage points).
  • Business Quant data shows ATNM's Return on Assets [ROA] at -48.29% (Q1 2026), -62.80% (Q4 2025) and -58.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - 26.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.42%
Mar 31, 2026 -48.29%
Dec 31, 2025 -62.80%
Sep 30, 2025 -58.07%
Jun 30, 2025 -62.33%
Mar 31, 2025 -62.54%
Dec 31, 2024 -48.10%
Sep 30, 2024 -47.58%
Jun 30, 2024 -47.83%
Mar 31, 2024 -54.71%
Dec 31, 2023 -57.94%
Sep 30, 2023 -54.61%
Jun 30, 2023 -47.60%
Mar 31, 2023 -37.48%
Dec 31, 2022 -29.50%
Sep 30, 2022 -25.81%
Jun 30, 2022 -27.92%
Mar 31, 2022 -31.80%
Dec 31, 2021 -30.12%
Sep 30, 2021 -27.46%
API Access

Actinium Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEY